Mandibular advancement splint

Sleep Apnea Oral Appliances Global Market Forecast Report to 2028 - Prominent Companies Include Somnomed, Resmed, Whole You, Prosomnus Sleep Technologies and Vivos Therapeutics

Retrieved on: 
Friday, January 12, 2024
Online, Obesity, Patient, Incidence, Sleep apnea, OTC, CPAP, Mandibular advancement splint, TRD, Project delivery method, USD, Tongue, Market, Physician, Growth, Pharmaceutical industry

Higher adoption of mandibular advancement devices accounts for the highest market share in the sleep apnea oral appliances market.

Key Points: 
  • Higher adoption of mandibular advancement devices accounts for the highest market share in the sleep apnea oral appliances market.
  • Based on purchase type, the sleep apnea oral appliances market is segmented into - physician-prescribed/ customized oral appliances and online OTC oral appliances.
  • The physician-prescribed/customized oral appliances segment dominated the sleep apnea oral appliances market with the largest share in 2022.
  • Sleep Apnea Oral Appliances Market, by Product, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Purchase Type, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Gender, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Age Group, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Distribution Channel, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by End-user, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Region, 2023 Vs. 2028 (USD Million)
    Sleep Apnea Oral Appliances Market, by Region (2023-2028) - Asia-Pacific to Register Highest CAGR During Forecast Period
    North America: Sleep Apnea Oral Appliances Market, by Product and Country (2021) - US Accounted for Largest Share of North American Sleep Apnea Oral Appliances Market in 2022
    Sleep Apnea Oral Appliances Market: Geographic Growth Opportunities - Countries in Asia-Pacific to Grow at Higher Rates During Forecast Period

Align Technology to Award Research Programs That Advance Orthodontic and Dental Patient Care

Retrieved on: 
Monday, November 7, 2022
Technology, Medical Devices, Dental, Health Technology, Software, Biotechnology, Other Health, Health, General Health, Orthodontics, NASDAQ, Software, Technology, Dentistry, Patient, Mandibular advancement splint, University, APAC, EMEA, Dentist, Science, Henry Ford Technical Fellow, GP, Health, ALGN, Align Technology, Research, Medical imaging, Align

Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2023 Research Award Program to support clinical and scientific dental research in universities across the globe.

Key Points: 
  • Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2023 Research Award Program to support clinical and scientific dental research in universities across the globe.
  • This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry.
  • Align Technologys Research Award Program has funded approximately $2.7 million in research since the programs inception in 2010.
  • Through Aligns annual research award program, we are proud to support orthodontic and dental science research studies that can ultimately improve treatment outcomes, said Dr. Mitra Derakhshan, Align vice president, global clinical.

Global Sleep Apnea Oral Appliances Market Report 2022: High Burden of Sleep Apnea to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 15, 2022
Medical Supplies, Medical Devices, Health, Hospitals, Telemedicine, Virtual Medicine, Managed Care, Online, Adoption, Mandibular advancement splint, TRD, Texas Homecare, Prevalence, Mads, Hospital, Population, Growth, USD, CPAP, Patient, OTC, Research, Sleep apnea, CAGR, Dentistry, Pharmaceutical industry

The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices & Tongue-Retaining Devices), Purchase Type (Physician-prescribed/Customized Oral Appliances & Online OTC Oral Appliances), End User (Homecare, Hospital) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices & Tongue-Retaining Devices), Purchase Type (Physician-prescribed/Customized Oral Appliances & Online OTC Oral Appliances), End User (Homecare, Hospital) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The mandibular advancement device segment accounted for the highest growth rate in the sleep apnea oral appliances market, by product, during the forecast period
    Based on product, the sleep apnea oral appliances market is divided into two main categories - mandibular advancement devices (MADs) and tongue-retaining devices (TRDs).
  • Base on purchase type, the sleep apnea oral appliances market is segmented into - physician-prescribed/ customized oral appliances and online OTC oral appliances.
  • The physician-prescribed/customized oral appliances segment accounted for the largest share of the sleep apnea oral appliances market in 2021.

Glidewell Introduces Addition to Its Silent Nite® Sleep Appliance Brand

Retrieved on: 
Wednesday, July 6, 2022
Patient, General practice, OSA, Data analysis, Orientation, CDT, GLOBE, Silent Night, D, Snoring, Mouth, Success, PDAC, Traction, Mandibular advancement splint, Dentist, Family, Glidewell, Medicare, Silent, Dentistry, Coding

This device is an extension of the Silent Nite brand, which dentists have been using since 1996 to treat snoring and obstructive sleep apnea (OSA).

Key Points: 
  • This device is an extension of the Silent Nite brand, which dentists have been using since 1996 to treat snoring and obstructive sleep apnea (OSA).
  • "I'm pleased to announce the availability of the Silent Nite with Glidewell Hinge," said Glidewell Founder and President Jim Glidewell, CDT.
  • The Silent Nite with Glidewell Hinge device works through bilateral compression, gently pushing the jaw into position.
  • To learn more or to receive information about the Glidewell Clinical Twinpak, which saves dentists $100 on a duplicate Silent Nite with Glidewell Hinge appliance to ensure uninterrupted treatment, call 800-854-7256 or visit glidewell.com/silent-nite-hinge .

Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea

Retrieved on: 
Tuesday, June 14, 2022
Apnea, Congress, Company, Snoring, Stroke, Dentist, Program, Securities Exchange Act of 1934, Drug Quality and Security Act, Apnea–hypopnea index, American Academy, CEO, Security (finance), CPAP, Mouth, Associated, U.S. Securities and Exchange Commission, Â, Heart failure, Depressive anxiety, VIP, Therapy, Manuscript, Patient, GLOBE, OSA, Risk, CARE, NASDAQ, Obstructive sleep apnea, Coronary artery disease, Mandibular advancement splint, Securities Act of 1933, Tissue, AHI, Pharmaceutical industry, Dentistry, Health insurance, Vivos

On June 6, 2022, Dr. Seth Heckman, Vivos Medical Advisory Board member, led a presentation, titled, Non-Surgical Maxillary Expansion Using A Novel Oral Appliance System.

Key Points: 
  • On June 6, 2022, Dr. Seth Heckman, Vivos Medical Advisory Board member, led a presentation, titled, Non-Surgical Maxillary Expansion Using A Novel Oral Appliance System.
  • The study participants experienced statistically significant increases in both transpalatal widths (4.5 percent) and airway volumes (11.1 percent).
  • Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for Home Sleep Testing in adults and children.
  • The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using The Vivos Method.

Vivos Therapeutics Opens State of the Art International Training Center In Denver

Retrieved on: 
Thursday, July 29, 2021
Vivos, Mandibular advancement splint, Health professional, Health

The Institutes emphasis will be on educating healthcare providers about OSA and Vivos treatments for OSA within their practice areas, along with training on Vivos related practice management tools for dentists.

Key Points: 
  • The Institutes emphasis will be on educating healthcare providers about OSA and Vivos treatments for OSA within their practice areas, along with training on Vivos related practice management tools for dentists.
  • Part of our mission is to spread the word about OSA among healthcare professionals who can help treat it.
  • The Vivos treatment for mild-to-moderate OSA involves a customized oral appliance and protocols called the Vivos System.
  • The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using the Vivos System.

Top Sleep Experts Convene To Address CPAP Alternatives

Retrieved on: 
Tuesday, July 27, 2021
Sleep disorders, Medicine, Clinical medicine, Branches of biology, Continuous positive airway pressure, Mandibular advancement splint, Obstructive sleep apnea, Sleep apnea, Sleep Research Society, Osa, Sleep surgery

They will convene to discuss barriers and facilitators for adoption of non-PAP treatment approaches to obstructive sleep apnea (OSA), including Oral Appliance Therapy (OAT).

Key Points: 
  • They will convene to discuss barriers and facilitators for adoption of non-PAP treatment approaches to obstructive sleep apnea (OSA), including Oral Appliance Therapy (OAT).
  • The Sleep Research Society Foundation (SRSF) and SomnoMed put focus on non-CPAP alternatives in light of Philips recall.
  • "Our partnership with the Sleep Research Society will help bring these discussions to the forefront and treat more patients more effectively."
  • "This is a timely and important discussion about the true positioning of non-PAP treatment alternatives and the implementation aspects of such therapies," reflects Sairam Parthasarathy, MD, Board of Director, Sleep Research Society and President, Sleep Research Society Foundation.

One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment

Retrieved on: 
Tuesday, July 13, 2021
Sleep disorders, Clinical medicine, Medicine, Branches of biology, Obstructive sleep apnea, Continuous positive airway pressure, Sleep apnea, Osa, Sleep surgery, Mandibular advancement splint

Patients who experienced little to no OSA symptoms may no longer require CPAP, neuro-stimulation, or other lifetime interventions.

Key Points: 
  • Patients who experienced little to no OSA symptoms may no longer require CPAP, neuro-stimulation, or other lifetime interventions.
  • Simply put, we believe this clinical data shows that our core technology is a game-changer for OSA sufferers who undergo the Vivos treatment.
  • A number of patients in the study remain in treatment, some of whom are also receiving CPAP therapy (except during sleep testing).
  • Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA).

ProSomnus® Sleep Technologies Names Global Scientific Committee Chair

Retrieved on: 
Friday, July 9, 2021
Sleep disorders, Branches of biology, Clinical medicine, Medicine, Obstructive sleep apnea, Sleep apnea, Mandibular advancement splint, Osa

SAN FRANCISCO, July 9, 2021 /PRNewswire/ -- ProSomnus Sleep Technologies, the leading Oral Appliance Therapy (OAT) medical device for the treatment of Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. Shouresh Charkhandeh as the Global Scientific Committee Chair.

Key Points: 
  • SAN FRANCISCO, July 9, 2021 /PRNewswire/ -- ProSomnus Sleep Technologies, the leading Oral Appliance Therapy (OAT) medical device for the treatment of Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. Shouresh Charkhandeh as the Global Scientific Committee Chair.
  • "Dr. Charkhandeh is an excellent and well qualified choice to lead this effort," states Dave Kuhns, PhD, Chief Science Officer at ProSomnus Sleep Technologies.
  • "We will facilitate and formalize this effort with the implementation of the ProSomnus Global Scientific Committee."
  • "His appointment as the Global Scientific Committee Chair is a testament to the commitment of ProSomnus to increase the collaboration between physicians and dentists and coordinate clinical research leading to the growing acceptance of OAT in the treatment of OSA."

GM Instruments, Ltd. Announces Partnership Agreement with Sensonics International

Retrieved on: 
Wednesday, June 2, 2021
Sleep disorders, Clinical medicine, Medicine, Branches of biology, Obstructive sleep apnea, Sleep apnea, Continuous positive airway pressure, Osa, Sleep surgery, Mandibular advancement splint

This union results in the promotion, co-distribution, and co-development of equipment critical for nasal and oral measurement.

Key Points: 
  • This union results in the promotion, co-distribution, and co-development of equipment critical for nasal and oral measurement.
  • One application relates to obstructive sleep apnea (OSA), a condition experienced by 1 out of every 15 adult Americans.
  • Accurate functional measures are sorely needed to assess the effects of CPAP and other treatments for OSA on nasal function, including smell dysfunction.
  • Sensonics International, founded in 1982 by Dr. Richard L. Doty of the University of Pennsylvania, is the world's purveyor of the finest quality smell and taste products.